Surveillance and characterization of Candida bloodstream infections in a Serbian tertiary care hospital

J Infect Dev Ctries. 2016 Jun 30;10(6):643-56. doi: 10.3855/jidc.7970.

Abstract

Introduction: Candida spp. frequently cause hospital-acquired bloodstream infections (BSI) with a high mortality rate (up to 70%). We analyzed the frequency, infection characteristics, potential predisposing factors, susceptibility to antifungal drugs, biofilm production and other virulence characteristics of Candida spp. isolates obtained from a tertiary care hospital in Niš, Serbia, during a one year period.

Methods: Medical histories, characteristics of isolated strains and drug susceptibility, as well as the effect on the function of isolated macrophages and other virulence features were evaluated. The obtained results were subjected to student's t-test and multivariate statistical analyzes.

Results: Herein we report an annual incidence of 3.65 cases of C. albicans, C. lusitaniae and C. lipolytica infections per 105 population. Out of eight isolated strains, two (25%) were shown to be strong biofilm producers, one (12.5%) caused hemolysis on blood agar and in two (25%) cases macrophages were able to completely eliminate the yeast colonies. Chronic kidney disease, diabetes, malignant and other diseases were present in 37.5, 62.5, 50 and 75%, respectively, in the study group. All patients with Candida BSI received antifungal therapy (amphotericin B), however, hospital mortality was observed in 25% of patients.

Conclusions: Evaluation of local Candida epidemiology, antifungal susceptibility and virulence factors, as well as personalized patient risk factors are important for the surveillance of Candida BSI, especially in intensive care unit patients and may contribute to the improved options and outcome for patients with Candida BSI.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use
  • Biofilms / growth & development
  • Candida / drug effects
  • Candida / isolation & purification*
  • Candida / pathogenicity
  • Candida / physiology*
  • Candidemia / drug therapy
  • Candidemia / epidemiology*
  • Candidemia / microbiology
  • Candidemia / mortality
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Epidemiological Monitoring
  • Female
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Macrophages / immunology
  • Macrophages / microbiology
  • Male
  • Middle Aged
  • Prospective Studies
  • Risk Factors
  • Serbia / epidemiology
  • Survival Analysis
  • Tertiary Care Centers
  • Virulence Factors / analysis
  • Virulence Factors / genetics
  • Young Adult

Substances

  • Antifungal Agents
  • Virulence Factors